Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.
about
Diversity and epidemiology of Mokola virusNovel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis.Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.Antigenicity of rabies virus glycoproteinFailure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infectionEntry kinetics and mouse virulence of Ross River virus mutants altered in neutralization epitopesAlphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virusCharacterization of saturable binding sites for rabies virusMolecular analysis of Sindbis virus pathogenesis in neonatal mice by using virus recombinants constructed in vitroLow-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus.Bats, emerging diseases, and the human interface.Novel vaccines to human rabiesA permanent host shift of rabies virus from Chiroptera to Carnivora associated with recombination.Characterization of a single-cycle rabies virus-based vaccine vector.Capped RNA transcripts of full-length cDNA clones of swine hepatitis E virus are replication competent when transfected into Huh7 cells and infectious when intrahepatically inoculated into pigs.An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitroComparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brainNeuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patientsEvidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicityRescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice.Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein.Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.Evidence for the control of phytolith formation in Cucurbita fruits by the hard rind (Hr) genetic locus: Archaeological and ecological implications.Mutants of rabies viruses in skunks: immune response and pathogenicity.A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity.Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001-2009.Sequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells.Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenicMolecular characterization of Korean rabies virus isolates.Recovery from and clearance of rabies virus in a domestic ferret.Three amino acid mutations (F51L, T59A, and S390L) in the capsid protein of the hepatitis E virus collectively contribute to virus attenuation.Rhabdovirus-based vaccine platforms against henipavirusesGenetic characterisation of the rabies virus vaccine strains used for oral immunization of foxes in Poland to estimate the effectiveness of vaccinationThe inability of wild-type rabies virus to activate dendritic cells is dependent on the glycoprotein and correlates with its low level of the de novo-synthesized leader RNA.Rabies virus nucleoprotein as a carrier for foreign antigens.Rabies vaccine preserved by vaporization is thermostable and immunogenicGeneration of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.iTRAQ protein profile analysis of neuroblastoma (NA) cells infected with the rabies viruses rHep-Flury and Hep-dG.
P2860
Q21092275-84E8ED2E-BE08-42D3-878F-9FC2F8F36608Q24520604-82A2DF01-A29F-4FF6-BF87-1939C87AE284Q24531953-DD364862-7CC5-4DAE-92C1-0F1BDC8D95E3Q24653467-30A9E17B-378A-4C13-BE07-BF79D1C1A1EBQ24675760-CACAEFD4-5932-4C92-AC92-886750A602BEQ27480336-76DC944C-57D5-4BBE-A438-17511347583BQ27486792-F1EB4C1A-6034-4CCF-81DC-CF17903009F4Q27486990-106E38B2-21C6-4B73-A829-D75FAE9874D0Q28776698-637D37B8-F221-4BD2-9E4E-6321D8F4D4C8Q31952001-33E3A0DB-520C-4554-9A1D-6997E1D7617DQ33487675-72256AE9-9CF8-4F8F-9D61-D6E691D13E65Q33507253-65F90908-2932-44B0-B36E-484D666E7E7FQ33670847-24323249-0357-4E80-B4DB-B2E0CD499B65Q33676502-700CA4E8-959D-4448-9BBE-D88E05E0D1C5Q33716547-0B80F5B8-6A46-447E-B9D8-1B9B949EB095Q33781965-10CF006C-B972-4A4E-AFD7-5379561B530AQ33784790-D6584CC6-0D74-4675-AD4E-E6E3E6A03736Q33785357-41D8EA9D-0943-4925-9732-EEF547C8FDDFQ33838289-4AC1FB90-EE56-43D5-B03B-97CBC6E3F330Q33845383-03715297-4DA8-498D-8A5E-CFBABBAF85DFQ33990518-675B5727-4302-48ED-8B9C-1AE38E3B6B79Q34050438-7D8A084A-7638-4FFF-BBBB-2AB7A7BCCDD7Q34055531-A9108F50-3244-4BAC-BDB1-537109D8ACAFQ34076372-BB852D47-FE5C-4F62-B544-76782FEABB79Q34081202-5E350089-C294-46B9-BD42-A97114B73358Q34124054-63FBC2B8-6367-4902-8016-DF4FFB06FD2BQ34318227-E45308A6-0AC5-463A-9BA6-4A24E9A9CA57Q34334103-4F7BE11B-93A4-4D24-B918-BDA20724789CQ34334320-DA986D4F-3E31-4557-82CB-1379913886A8Q34461764-F33F7A3C-DEF3-43C8-B353-B2EBBFD602D8Q34648145-3751FFB5-A63C-4133-820A-77411CB104ACQ34701386-2C62D1DE-B4E9-4EA0-A75A-A613410CF1EDQ34982710-29A4DAD5-6213-4A3F-9DA4-CFD4B79D0C6BQ34992537-1A94337F-16C4-4A7C-8FBB-DBDFC4845D00Q35043707-C6062195-F97A-44C3-B3BD-A6952FFE5971Q35115568-E65771CA-5410-42BB-AB2A-4F05319E0CEEQ35320069-395C0F72-7641-45AF-B9BD-9EF2CF652686Q35434725-A03F091C-139E-4DCD-BC0F-CF7C1A979E8BQ35478263-AC2AEBB0-1F25-4AEA-9848-F46D73179B4DQ35825427-6818751D-264B-494A-A9C6-04FF9630D55F
P2860
Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of an antigen ...... pathogenicity of rabies virus.
@en
Characterization of an antigen ...... pathogenicity of rabies virus.
@nl
type
label
Characterization of an antigen ...... pathogenicity of rabies virus.
@en
Characterization of an antigen ...... pathogenicity of rabies virus.
@nl
prefLabel
Characterization of an antigen ...... pathogenicity of rabies virus.
@en
Characterization of an antigen ...... pathogenicity of rabies virus.
@nl
P2093
P2860
P356
P1476
Characterization of an antigen ...... pathogenicity of rabies virus.
@en
P2093
B Dietzschold
H Koprowski
T J Wiktor
W H Wunner
P2860
P356
10.1073/PNAS.80.1.70
P407
P577
1983-01-01T00:00:00Z